Neurodivergent News

Researchers Build the Largest Molecular Map of Autism Yet

UCSF researchers mapped more than 1,800 protein interactions involving 100 high-confidence autism-risk genes. About 87% of those interactions had not previously been reported.

The researchers found that several distinct genetic variants appear to disrupt some of the same protein complexes and molecular pathways. This could eventually help scientists identify shared targets for precision treatments.

Why it matters: This is an important advance in understanding how certain rare, high-impact genetic variants affect brain development. It is early-stage research—not a new autism treatment, explanation for every form of autism or cure.

Neurodivergent Students Say Research Should Focus on Real-World Barriers

Researchers asked 104 current and former neurodivergent higher-education students in the United Kingdom what mental-health research should prioritize.

Participants called for greater attention to institutional barriers, stigma, diagnostic pathways, underrepresented groups and whether existing support actually improves students’ lives. They also favored needs-based support over systems that require a formal diagnosis before help becomes available.

Why it matters: Research priorities are often established without giving the people most affected a meaningful voice. This study puts lived experience closer to the center of that process.

Important context: This is a preprint and has not yet completed peer review.

New Data Show How Common ADHD Is Among U.S. Children

CDC data collected in 2024 estimate that 7 million U.S. children ages 3–17—about 11.7%—have a parent-reported current ADHD diagnosis.

Separate 2022 survey data found that nearly 2 million children with current ADHD received neither ADHD medication nor behavioral treatment.

Why it matters: Diagnosis, treatment and support are not the same thing. However, the treatment data do not explain why treatment was absent or account for every accommodation, service or informal support a child may have received.

Important context: The prevalence estimate comes from 2024; the treatment estimate comes from 2022. They should not be presented as one dataset.

Workplace Awareness Is Growing—but Fear of Disclosure Remains

A 2026 Understood.org survey found that 70% of neurodivergent employees worry that disclosing their neurodivergence could negatively affect them at work.

The survey also found that 70% did not know which accommodations they were entitled to, while 60% did not know whom to approach to request them. Meanwhile, 78% of neurodivergent employees reported using AI tools at work, compared with 59% of neurotypical employees.

Why it matters: A workplace can describe itself as inclusive while employees still feel unsafe asking for support. AI may help with some tasks, but technology cannot replace clear policies, informed managers and psychological safety.

Survey context: The Harris Poll surveyed 2,073 U.S. adults, including 614 who identified as neurodivergent.

What gaze-tracking research can—and can't—tell us

A new meta-analysis found that gaze-tracking tests identified autism in children with roughly 77% sensitivity and 80% specificity. Dynamic social videos and higher-quality cameras performed best. The results suggest possible value as one part of assessment—not a stand-alone diagnostic test—and variation between studies remains substantial.

Sensory-seeking and executive function in young autistic children

In a study of 63 young autistic children, sensory-seeking or repetitive sensory behavior was associated with greater executive-function difficulty across both caregiver reports and observations. The small sample and largely correlational design mean the findings cannot establish causation.

Late diagnosis and gender diversity

A study of 2,722 predominantly late-diagnosed autistic people found that gender-diverse participants reported more co-occurring psychiatric diagnoses and more perceived prior misdiagnoses than cisgender participants. Because the sample was already weighted toward late diagnosis and relied partly on participant perceptions, the results may not generalize to all autistic people.

Stronger controls weaken reported acetaminophen links

Recent matched-sibling evidence continues to weaken claims that prenatal acetaminophen use causes autism or ADHD: associations seen in conventional observational comparisons moved toward null results when shared family and genetic factors were better controlled. Residual uncertainty remains inherent to observational research.

Federal autism committee extends public comment period

The U.S. Interagency Autism Coordinating Committee extended public comment on its draft 2026–2028 strategic plan until August 20 at 5 p.m. ET after advocacy organizations argued that the original four-day period was inadequate. The draft could shape federal priorities for research, services, communication access, and accountability. The extension is meaningful, although several organizations had requested 90 days.

Three tensions shaping neurodivergence conversations online

• whether “neurodivergent” has become shorthand mainly for autism and ADHD, obscuring other conditions;
• whether social-media content improves recognition for overlooked adults or encourages oversimplification and casual self-diagnosis;
• how identity-affirming accounts of autism can coexist with the substantial disability and support needs experienced by other autistic people.

A 2026 analysis confirms the broader trend: autism and ADHD became increasingly central in Reddit mental-health discourse from 2015–2022. That study measures changing language and attention, not diagnostic prevalence or clinical truth.